Navigation Links
GeneGo Collaborates With The Netherlands Toxicogenomics Center on $100 Million Grant
Date:2/13/2008

ST. JOSEPH, Mich., Feb. 13 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that they will be collaborating with The Netherlands Toxicogenomics Center (NTC). This 5 year, 25 Million Euro, multi-party program will use toxicogenomics to develop highly predictive 'omics-based screens, to be used for the in depth evaluation of chemical safety for human health, replacing, reducing or refining animal experiments, and improving the scientific basis of chemical risk assessment.

The NTC will use GeneGo's MetaCore and MetaDrug systems biology data analysis platform to coordinate, visualize and interpret chemical, metabolomic, proteomic and gene expression data generated by the project members, and to identify the key biological functions and pathways contributing to the adverse effects of xenobiotic exposure. GeneGo will further contribute by working within the bioinformatics workgroup of the NTC to build predictive models, using GeneGo's "Functional Descriptor" technology, for the earlier identification of adverse effects in animals from short-term in vivo experiments, or from in vitro experiments using cells in place of animals.

Professor Jos Kleinjans, Director of the NTC said "having GeneGo as a partner in the project, and having access to their leading systems biology data visualization and analysis tools and expertise, will help us to derive the best value from the data we are generating and make progress in the application of an integrated systems toxicology approach to risk assessment."

Dr. Richard Brennan, Director of Toxicology at GeneGo, said, "We are delighted to be a part of this exciting and ambitious project. The tools we have developed at GeneGo are an excellent solution for analyzing the multiple data types that will be generated by the NTC members and for understanding the biological basis of chemically-induced toxicity. The project will help us to further validate and develop our capabiliti
'/>"/>

SOURCE GeneGo
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. GSK Extends GeneGo License and Adds New Products
2. UC Berkeley Expands Molecular Toxicology Curriculum to Include GeneGos Platform
3. GeneGo Integrates With Cytoscape
4. Utrecht University Licenses MetaDrug From GeneGo for Drug Innovation
5. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
6. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
7. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
8. Millstone Medical Outsourcing Relocates Memphis Distribution Center Within 72 Hours of Tornado Disaster
9. Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to The Nebraska Medical Center
10. The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions
11. Tom Shaws NFL Training Center Chooses SURGEX(TM) as Their Exclusive Post Training Nutritional Regimen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Topricin Pain Relief and ... been listed among nationally recommended over-the-counter (OTC) health ... by "U.S. News" Health in collaboration with "Pharmacy ... “No. 1 Pharmacists Recommended designation” in the “Topical ... brands, and is the only homeopathic formula to ...
(Date:5/17/2013)... Photographers know the ... see which branch a bird is sitting on, but spotting ... lens for high-magnification images requires considerable skill. It is a ... the active biomolecules of cells. , Olga Schubert, a doctoral ... her colleagues have now come up with a search aid. ...
(Date:5/17/2013)... 2013 New interactive learning ... thought leaders of the medical device industry at ... and expo, from June 18-20 in ... http://photos.prnewswire.com/prnh/20130517/613829 ) , These all-new ... professionals practical presentations and implementable solutions on the ...
(Date:5/17/2013)... MIAMI , May 17, 2013  Insero Health, ... medical needs in epilepsy and related neurological disorders, is ... of its lead compound INS001 in patients with drug-resistant ... Drug and Device Trials (AED) Xll meeting by Dr. ... epileptologist and Chairman of Insero,s Scientific Advisory Board.  In ...
Breaking Biology Technology:Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2
... rise 3% over Fiscal 2006 to $27.5 million - ... Canadian dollars unless otherwise noted), BELLEVILLE, ON, Sept. ... research-based, technology-driven Canadian,biopharmaceutical company, today announced financial results for ... recent announcements of the first shipment and commercial usage ...
... Nastech,Pharmaceutical Company Inc. (Nasdaq: NSTK ) will be ... City on Thursday, October 4, 2007,from 12:00 p.m. - ... at Times,Square, on 270 West 43rd Street. The luncheon ... Ph.D., Chairman, President and,Chief Executive Officer and Gordon Brandt, ...
... is pleased to announce that the majority shares in ... Tampa,FL. (http://www.healthedgepartners.com ). Paul Guilbaud, ABT President ... exciting development of ABT. The acquisition allows us to ... necessary infrastructure for our,world- wide sales expansion and allow ...
Cached Biology Technology:Bioniche Reports Fiscal 2007 Year-End Results 2Bioniche Reports Fiscal 2007 Year-End Results 3Bioniche Reports Fiscal 2007 Year-End Results 4Bioniche Reports Fiscal 2007 Year-End Results 5Bioniche Reports Fiscal 2007 Year-End Results 6Bioniche Reports Fiscal 2007 Year-End Results 7Bioniche Reports Fiscal 2007 Year-End Results 8Bioniche Reports Fiscal 2007 Year-End Results 9Bioniche Reports Fiscal 2007 Year-End Results 10Nastech to Host 2007 Analyst and Institutional Investor Day 2Nastech to Host 2007 Analyst and Institutional Investor Day 3Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL 2
(Date:5/16/2013)... lining the body,s blood vessels, is extremely resilient. ... this super-tenuous structure routinely withstands blood flow, hydrostatic ... unique and highly dynamic barrier that maintains the ... circulatory system. , It,s also extremely adaptable. In ... to enable immune cells to reach various ...
(Date:5/16/2013)... A scientist has discovered an ancient extinct creature with ... it in honour of his favourite movie star. ... Kooteninchela deppi (pronounced Koo-ten-ee-che-la depp-eye), which is a ... the actor Johnny Depp for his starring role as ... named Edward, an unfinished creation, who has scissors for ...
(Date:5/16/2013)... the world are meeting next week in Toronto. ... the latest in research findings about the brain, ... the disorders that affect them., "Canada is a ... showcase the best of neuroscience research done here ... of the Canadian Association for Neuroscience. He also ...
Breaking Biology News(10 mins):Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4Actor Johnny Depp immortalized in ancient fossil find 27th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2
... for Biological Studies show that the only human gene ... is, in fact, riskier than realized. , The ... in the Laboratory of Genetics, discovered that the healthy ... cancer development. Their findings appear in this week's issue ...
... virus H5N1, derived from horses, prevent mice infected with ... study published today in the open access journal Respiratory ... 100 µg of horse anti-serum effectively protects infected mice. ... could potentially be used to prevent death from H5N1 ...
... Marine scientists have discovered that the deepest oceans of the ... a paper published today, an international team of researchers, led ... to colonise at depths greater than 3,000 metres. , Sharks ... that as man explores deeper into the abyss and beyond ...
Cached Biology News:Mouse study reveals human X-SCID gene therapy poses substantial cancer risk 2Mouse study reveals human X-SCID gene therapy poses substantial cancer risk 3Oceans are 70 percent shark free 2
Negative Control, eluted and packaged aseptically in 20l of 10mM Tris-HCL, pH 8.0, 1 mM EDTA, 5 years at either 4°C or -20°C...
Medium for cryopreserving subcutaneous or omental preadipocytes...
AdestaTM Tissue/Cell Preservation Medium Sterile / Non-sterile: Sterility Tested Endotoxin: ...
... ultra high yield technology is fast - ... aRNA for gene array analysis ... , Kits specific for templates with ... , All kits contain SUPERaseIn ...
Biology Products: